BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar S, Alam MN, Rai S, Bashir T, McGinty D, Szymusiak R. Central nervous system sites of the sleep promoting effects of eszopiclone in rats. Neuroscience 2011;181:67-78. [PMID: 21382446 DOI: 10.1016/j.neuroscience.2011.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Doty RL. Gustation. Wiley Interdiscip Rev Cogn Sci 2012;3:29-46. [PMID: 26302471 DOI: 10.1002/wcs.156] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kumar S, Rai S, Hsieh KC, McGinty D, Alam MN, Szymusiak R. Adenosine A(2A) receptors regulate the activity of sleep regulatory GABAergic neurons in the preoptic hypothalamus. Am J Physiol Regul Integr Comp Physiol 2013;305:R31-41. [PMID: 23637137 DOI: 10.1152/ajpregu.00402.2012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
3 Rihel J, Schier AF. Sites of action of sleep and wake drugs: insights from model organisms. Curr Opin Neurobiol 2013;23:831-40. [PMID: 23706898 DOI: 10.1016/j.conb.2013.04.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
4 Cui Y, Zhang Y, Liu G. Syringin may exert sleep-potentiating effects through the NOS/NO pathway. Fundam Clin Pharmacol 2015;29:178-84. [DOI: 10.1111/fcp.12095] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
5 Richter G, Liao VWY, Ahring PK, Chebib M. The Z-Drugs Zolpidem, Zaleplon, and Eszopiclone Have Varying Actions on Human GABA A Receptors Containing γ1, γ2, and γ3 Subunits. Front Neurosci 2020;14:599812. [PMID: 33328871 DOI: 10.3389/fnins.2020.599812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Kim JW, Kim CS, Hu Z, Han JY, Kim SK, Yoo SK, Yeo YM, Chong MS, Lee K, Hong JT, Oh KW. Enhancement of pentobarbital-induced sleep by apigenin through chloride ion channel activation. Arch Pharm Res 2012;35:367-73. [PMID: 22370792 DOI: 10.1007/s12272-012-0218-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
7 Moore JT, Chen J, Han B, Meng QC, Veasey SC, Beck SG, Kelz MB. Direct activation of sleep-promoting VLPO neurons by volatile anesthetics contributes to anesthetic hypnosis. Curr Biol 2012;22:2008-16. [PMID: 23103189 DOI: 10.1016/j.cub.2012.08.042] [Cited by in Crossref: 100] [Cited by in F6Publishing: 93] [Article Influence: 10.0] [Reference Citation Analysis]
8 Zhang Y, Su J, Wang J, Tang G, Hu W, Mao J, Ren W, Liu Y, Yu Z. Cognitive behavioral therapy for insomnia combined with eszopiclone for the treatment of sleep disorder patients transferred out of the intensive care unit: A single-centred retrospective observational study. Medicine (Baltimore) 2018;97:e12383. [PMID: 30213004 DOI: 10.1097/MD.0000000000012383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
9 Methippara M, Mitrani B, Schrader FX, Szymusiak R, McGinty D. Salubrinal, an endoplasmic reticulum stress blocker, modulates sleep homeostasis and activation of sleep- and wake-regulatory neurons. Neuroscience 2012;209:108-18. [PMID: 22387272 DOI: 10.1016/j.neuroscience.2012.02.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
10 Filbey WA, Sanford DT, Baghdoyan HA, Koch LG, Britton SL, Lydic R. Eszopiclone and dexmedetomidine depress ventilation in obese rats with features of metabolic syndrome. Sleep 2014;37:871-80. [PMID: 24790265 DOI: 10.5665/sleep.3650] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]